Quick Answer
ADAPTIN BIO, INC. reported Common Stock Shares Outstanding of 5.00 million shares for the year ending 2024.
- ADAPTIN BIO, INC. showed an increase of +0.0% in Common Stock Shares Outstanding from 2023 to 2024.
- This data is from ADAPTIN BIO, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2023: 5.00 million shares | Q1 2024: 5.00 million shares | Q2 2024: 5.00 million shares | Q3 2024: 5.00 million shares | Q4 2024: 3.25 million shares | Q1 2025: 8.40 million shares | Q2 2025: 8.46 million shares | Q3 2025: 8.46 million shares.
- Over the full 3 years of available data (2022 to 2024), ADAPTIN BIO, INC.'s Common Stock Shares Outstanding has grown by 0.0%.
- Historical annual values: Fiscal year 2024: 5.00 million shares | Fiscal year 2023: 5.00 million shares | Fiscal year 2022: 5.00 million shares.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: